Douglas Orr
- Immunology top 5%
- Immune Cell Function and Interaction 3
- Immunotherapy and Immune Responses 3
- Oncology top 5%
- CAR-T cell therapy research 4
- HER2/EGFR in Cancer Research 4
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Hematology top 10%
- Biotechnology top 10%
-
- Chronic Lymphocytic Leukemia Research 3
-
- Liver Disease Diagnosis and Treatment 3
-
- Monoclonal and Polyclonal Antibodies Research 3
- Co-authors
- Kurt W. TauerJohn R. YannelliGailen D. MarshallWilliam H. WestGary B. ThurmanRobert K. OldhamRobert M. GoldsteinJane Dempster
- Cited by
- ImmunologyOncologyHepatology
- Journals
- Journal of Clinical Oncology (4 papers)JNCI Journal of the National Cancer Institute (1 paper)Journal of Hepatology (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Douglas Orr
19 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Immunology 760
- Oncology 686
- Hepatology 107
- Hematology 102
- Biotechnology 70
Countries citing papers authored by Douglas Orr
This map shows the geographic impact of Douglas Orr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Orr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Orr more than expected).
Fields of papers citing papers by Douglas Orr
This network shows the impact of papers produced by Douglas Orr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Orr. The network helps show where Douglas Orr may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Douglas Orr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 6 | |
| 3 | 2014 | 41 | |
| 4 | 2008 | 169 | |
| 5 | 2008 | 10 | |
| 6 | 2006 | 34 | |
| 7 | 2003 | 49 | |
| 8 | 2003 | 11 | |
| 9 | 2000 | 1 | |
| 10 | Phase I trial of retroviral vector-mediated interferon (IFN)-gamma gene transfer into autologous tumor cells in patients with metastatic melanoma. | 1999 | 32 |
| 11 | 1999 | 6 | |
| 12 | 1991 | 87 | |
| 13 | Patterns of cytokines released by peripheral blood leukocytes of normal donors and cancer patients during interleukin-2 activation in vitro. | 1990 | 13 |
| 14 | 1989 | 5 | |
| 15 | Phase I trial of mitomycin C immunoconjugates cocktails in human malignancies. | 1989 | 5 |
| 16 | 1988 | 5 | |
| 17 | 1988 | 12 | |
| 18 | Adriamycin custom-tailored immunoconjugates in the treatment of human malignancies. | 1988 | 14 |
| 19 | Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancerbreakdown → | 1987 | 974 |
About Douglas Orr
Douglas Orr is a scholar working on Oncology, Hepatology, Genetics, Immunology and Biotechnology, having authored 19 papers that have together received 1.5k indexed citations. Recurring topics across this work include CAR-T cell therapy research (4 papers), HER2/EGFR in Cancer Research (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Immune Cell Function and Interaction (3 papers), Immunotherapy and Immune Responses (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Immunology (760 citations), Oncology (686 citations), Hepatology (107 citations), Hematology (102 citations) and Biotechnology (70 citations). Douglas Orr has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Kurt W. Tauer, John R. Yannelli, Gailen D. Marshall, William H. West, Gary B. Thurman, Robert K. Oldham, Robert M. Goldstein, Jane Dempster, Gary L. Davis and Brian D. Brown. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute, Journal of Hepatology, Digestive Diseases and Sciences and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.